Monday, September 17, 2007

VLST Corp. Adds Vice President, Senior Director

VLST Corp., a biotechnology company that specializes in the development of therapeutics for autoimmune and inflammatory disorders, revealed Monday that it has made two new appointments to its executive staff. The Seattle-based company said it has hired Consuelo M. Blosch M.D. as vice president of clinical and regulatory and Dan Allison Ph.D as senior director of therapeutic design. Blosch joins VLST from the Benaroya Research Institute at Virginia Mason, where she served as administrative director of the BRI Clinical Research Program. She has also held director-level positions at Immunex Corp. and NPS Pharmaceuticals Inc. Allison comes to VLST from ICOS Corp., where he most recently served as senior director for product development. Prior to ICOS, Allison worked at Genencor International. VLST is venture backed by Accelerator, Amgen Ventures, ARCH Venture Partners, MedImmune Ventures, MPM Capital, OVP Venture Partners, TPG Ventures and WRF Capital.